Jushi Holdings (JUSHF) Notes Payables (2023 - 2026)

Jushi Holdings (JUSHF) posted quarterly Notes Payables of $11000.0 for Q2 2026, down 92.09% quarter-over-quarter from $139000.0 in Q1 2026.

Jushi Holdings (JUSHF) Notes Payables (2023 - 2026) Analysis & Trends

Jushi Holdings (JUSHF) has reported Notes Payables for 4 consecutive years, with $11000.0 the latest figure, recorded in Q2 2026.

In Q2 2026, Notes Payables changed N/A year-over-year to $11000.0; the TTM figure through Jun 2026 stood at $11000.0 (changed N/A YoY), while the FY2025 annual figure was $296000.0, changed N/A from the prior year.
Notes Payables declined to $11000.0 in Q2 2026 per JUSHF's latest filing, from $139000.0 in the prior quarter.
Across five years, Notes Payables topped out at $7.2 million in Q1 2024 and bottomed at $11000.0 in Q2 2026.
Historically, Notes Payables has averaged $1.8 million across 4 years, with a median of $296000.0 in 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Haleon	43.89 Bn	42.93 Bn	-
2	Teva Pharmaceutical Industries	43.01 Bn	39.35 Bn	2.15 Bn
3	Zoetis	31.52 Bn	29.84 Bn	1.05 Bn
4	Takeda Pharmaceutical	28.61 Bn	22.81 Bn	5.10 Bn
5	United Therapeutics	22.17 Bn	19.51 Bn	683.80 Mn
6	Viatris	18.73 Bn	17.85 Bn	1.46 Bn
7	Neurocrine Biosciences	15.51 Bn	15.12 Bn	935.80 Mn
8	Elanco Animal Health	11.75 Bn	11.22 Bn	798.00 Mn
9	Dr Reddys Laboratories	10.12 Bn	9.96 Bn	-
10	Jushi Holdings	83.87 Mn	50.54 Mn	31.53 Mn

Download Data